HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Female pseudohermaphroditism and inefficient peak bone mass in an untreated subject affected by 21-hydroxylase congenital adrenal hyperplasia.

Abstract
Here we describe a subject with congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21-CAH), in its classical virilizing form, who presented at birth ambiguous genitalia and subsequently was assigned by the parents as male. At the age of 8 years, he underwent a two-step surgical correction of hypospadia and at 22 years old, uterus and ovaries were removed and a bilateral testicular prothesis was surgically placed in scrotum. He refused any chronic glucocorticoid therapy, that was given only acutely to prevent adrenal crises during stress, trauma surgery or severe illness. The patient is now 38 years old, he is genotypically female but phenotypically male, with high endogenous levels of androgen, all of adrenal origin, and with an apparent male sexual life. He had severe osteopenia, probably due to the lack of estrogen/androgen-induced increase in bone mineral density, although periferal estrogen conversion was normal. His skeletal mass, in fact, normally acquired during adolescence and early adult life, could in this case be inefficient, for the precocious pseudopuberty, that caused an inefficient peak bone mass in adolescence period.
AuthorsR Valentino, S Savastano, A P Tommaselli, M Dorato, M T Scarpitta, E Calvanese, A Del Puente, G Lombardi
JournalJournal of endocrinological investigation (J Endocrinol Invest) Vol. 23 Issue 5 Pg. 317-20 (May 2000) ISSN: 0391-4097 [Print] Italy
PMID10882150 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Androgens
  • Diphosphonates
  • Vitamin D
  • Calcium
Topics
  • Adrenal Hyperplasia, Congenital (complications)
  • Adult
  • Androgens (blood, urine)
  • Bone Density
  • Bone Diseases, Metabolic (drug therapy, etiology)
  • Calcium (therapeutic use)
  • Diphosphonates (therapeutic use)
  • Disorders of Sex Development (etiology)
  • Female
  • Humans
  • Phenotype
  • Spine
  • Vitamin D (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: